secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0000899923-23-000110
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics raises ~$110M via public offering of 6.47M shares at $17/sh
---------------------------------------------------------------------------

- Entered underwriting agreement with Goldman Sachs, Morgan Stanley, and Wells Fargo to sell 6,470,588 shares at $17.00/share.
- Underwriters have a 30-day option to purchase up to 970,588 additional shares.
- Offering closed on November 13, 2023; net proceeds after underwriting discounts and commissions not specified.
- Prospectus supplement filed under automatic shelf registration statement (File No. 333-275396).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992323000110/0000899923-23-000110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992323000110/mygn-20231108.htm
  HTML page:      https://secwatch.observer/filing/0000899923-23-000110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer